Benign Conditions

Latest News

FDA grants 510(k) clearance to RELIEF stent for vesicoureteral reflux
FDA grants 510(k) clearance to RELIEF stent for vesicoureteral reflux

January 14th 2025

In a recent study of the RELIEF stent, 95% of patients showed no VUR following stent placement.

In-depth study of microbiomes may lead to better UTI care for patients with spina bifida
In-depth study of microbiomes may lead to better UTI care for patients with spina bifida

January 6th 2025

FDA logo
2024 Urology Times pipeline report

January 1st 2025

ELIMINATE trial: uUTI regimen demonstrates initial tolerability, efficacy
ELIMINATE trial: uUTI regimen demonstrates initial tolerability, efficacy

November 1st 2024

FDA approves oral sulopenem for uncomplicated urinary tract infection
FDA approves oral sulopenem for uncomplicated urinary tract infection

October 25th 2024

More News

© 2025 MJH Life Sciences

All rights reserved.